


ADC Therapeutics SA is a clinical-stage biotechnology company, which engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epa
Opening Hour: Trading Days: 09:00-18:00
Non-trading Days: Closed
Opening Hour: 9am - 6pm (Mon - Sat)
Close (Sun and Public Holiday)
Opening Hour: 9am - 6pm (Mon - Sat)
Close (Sun and Public Holiday)
Opening Hour: 9am - 6pm (Mon - Sat)
10am - 6pm (Sun and Public Holiday)
Opening Hour: 9am - 6pm (Mon - Sat)
10am - 6pm (Sun and Public Holiday)
Opening Hour: 10am - 9pm (Mon - Sat)
10am - 6pm (Sun and Public Holiday)
Opening Hour: 10am - 9pm (Mon - Sat)
10am - 6pm (Sun and Public Holiday)
Opening Hour: 10am - 7pm (Mon - Sat)
10am - 6pm (Sun and Public Holiday)
Copyright © 2022 uSMART . All Rights Reserved.